BioCryst Pharmaceuticals began using LinkedIn for company updates.
3 reports, 2 independent
Updated Aug 21
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioCryst Pharmaceuticals began using LinkedIn for company updates.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BioCryst Pharmaceuticals started using LinkedIn for company updates.1 source
A company started following BioLife on LinkedIn.1 source
Keep exploring
The entities involved
-
BioCryst Pharmaceuticals
American pharmaceutical company
-
LinkedIn
American social networking website for people in professional occupations
-
BIOLIFE
Slovak company
Nothing else this week.
Related events
- Edgewise Therapeutics announced news from Boulder, Colorado, and utilizes LinkedIn for its public communication.
- Srinivasan has joined LinkedIn as the Chief Product Officer.
- Lenovo uses LinkedIn for professional announcements, and a staff member transitioned from Parle Agro to the company.
- LinkedIn was mentioned in connection with New York City as a place to follow for updates.
- Nasdaq directs interested parties to LinkedIn for company information.
Coverage
Newest first; wire copies grouped- GlobeNewswireBioCryst to Present at Upcoming Investor Conference RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plan
- PR NewswireBioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 BOTHELL, Wash., July 24, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading
- GlobeNewswireBioCryst to Report Second Quarter 2025 Financial Results on August 4 RESEARCH TRIANGLE PARK, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that